COVID-19-related dynamic coagulation disturbances and anticoagulation strategies using conventional D-dimer and point-of-care Sonoclot tests: a prospective cohort studyArticle Published on 2022-05-022022-10-04 Journal: BMJ Open [Category] 임상, [키워드] 28-day mortality abnormality Admission admitted to ICU amplitude Analysis anticoagulation association bleeding bleeding event C reactive protein Care change Coagulation coagulation test contributed Course COVID-19 Critical Critical care cut-off D-dimer defined demonstrated Descriptive analysis groups hazard hospital hypercoagulable hypocoagulable ICU India Intensive intensive & intensive care invasive ventilation Logistic regression mechanical ventilation Mortality North overall mortality Patient performed Platelet Pneumonia point-of-care predicted predictor Presence procoagulant prospective cohort study Prothrombin time pulmonary microthrombosis Respiratory failure risk secondary outcome Severe COVID-19 pneumonia subjects Tertiary the disease thromboembolic thromboembolic complications Thromboembolism Treatment was used were assessed were used with COVID-19 [DOI] 10.1136/bmjopen-2021-051971 PMC 바로가기 [Article Type] Article
High incidence of pulmonary thromboembolism in hospitalized SARS-CoV-2 infected patients despite thrombo-prophylaxis혈전 예방에도 불구하고 입원한 SARS-CoV-2 감염 환자에서 폐혈전색전증의 높은 발생률Observational Study Published on 2022-05-012022-09-11 Journal: Heart & lung : the journal of critical care [Category] COVID19(2023년), SARS, 임상, 치료기술, [키워드] Admission age caused Characteristics Coagulation Computed tomography coronavirus COVID-19 COVID-19 pneumonia CTPA D-dimer levels diagnosed Diagnosis died Endothelial cell endothelial cells European hospital hospitalised Hospitalization Hospitalized incidence infected patient Infection Injury median age much lower Negative PCR no differences no significant differences non-infected Observational cohort study one patient Patient patient mortality patients patients with COVID-19 patients with PE performed Pneumonia Pulmonary thromboembolism reported retrospective observational cohort study SARS-CoV-2 SARS-CoV-2 infected patient SARS-CoV-2 infected patients SARS-CoV2 Sex significant difference study period suspicion the patient those without PE Thromboembolism thrombosis thrombotic thrombotic complication Thrombotic complications two groups virus infection VTE [DOI] 10.1016/j.hrtlng.2022.02.003 PMC 바로가기 [Article Type] Observational Study
Anticoagulation in COVID-19: current concepts and controversiesReview Published on 2022-05-012023-07-06 Journal: Postgraduate medical journal [Category] COVID19(2023년), [키워드] anticoagulation COVID-19 internal medicine Thromboembolism [DOI] 10.1136/postgradmedj-2021-139923 [Article Type] Review
Venous thromboembolism in patients hospitalised with COVID-19 in EnglandObservational Study Published on 2022-05-012022-10-05 Journal: Thrombosis research [Category] 임상, [키워드] 95% confidence interval adjusted Admission Analysis black coronavirus covariates COVID-19 dataset Diagnosis diagnosis of COVID-19 discharge England exploratory Hospital Episode Statistics Hospital stay hospitalisation with COVID-19 hospitalised in-hospital mortality incidence main analysis male mortality rate Observational data Odds ratio over Patient Primary outcome pulmonary Pulmonary embolism recorded Retrospective analysis subsequent Thromboembolism unique Venous Thromboembolism VTE with COVID-19 [DOI] 10.1016/j.thromres.2022.03.017 PMC 바로가기 [Article Type] Observational Study
Comparison of standard prophylactic, intermediate prophylactic and therapeutic anticoagulation in patients with severe COVID-19: protocol for the ANTICOVID multicentre, parallel-group, open-label, randomised controlled trial중증 COVID-19 환자에 대한 표준 예방, 중간 예방 및 치료 항응고 요법의 비교: ANTICOVID 다기관, 병렬 그룹, 공개 라벨, 무작위 대조 시험에 대한 프로토콜Article Published on 2022-04-262022-09-11 Journal: BMJ Open [Category] 임상, [키워드] absence all-cause mortality anticoagulation approved bleeding body mass body mass index Clinical improvement Clinical practice clinical scale Coagulopathy component Computed tomography COVID-19 criterion D-dimer D-dimer level D-dimer levels death defined dysfunction Efficacy and safety ethical committee Ethics ethics committee Evolution extension extreme followed by France French Hierarchical High-dose Hospital stay Ile include induce intensive care intensive care unit Invasive mechanical ventilation life low-dose lung major bleeding event Microvascular thrombosis multicentre Multiorgan Open-label outcome oxygen parallel-group Paris pathophysiological Patient patients patients with COVID-19 peer-reviewed primary endpoint Prophylactic protocol pulmonary artery Quality of life randomisation randomised randomised controlled randomised controlled trial randomised trials receive recruit registration number renal renal failure respiratory respiratory infections secondary Secondary outcomes Sepsis sepsis-induced coagulopathy severe COVID-19 stratified submitted the primary endpoint therapeutic anticoagulation Thromboembolism thrombosis thrombotic Trial trials Vasopressor venous ventilator weight [DOI] 10.1136/bmjopen-2021-059383 PMC 바로가기 [Article Type] Article
COVID-19 and thrombosis: The role of hemodynamicsReview article Published on 2022-04-012022-10-05 Journal: Thrombosis research [Category] COVID19(2023년), SARS, 진단, [키워드] addition addressed adverse outcome Affect Brain characterized classical coronavirus disease COVID-19 COVID-19 case Critical crux Cytokine storm diagnostic Disseminated intravascular coagulation dysfunction Effect endothelial injury expressed Factor growth hemodynamic Hemodynamics hypercoagulability hypothese increased risk Injury investigated kidneys Lungs mechanism Microvascular thrombosis neutrophil offer organ pathway Patient Patient care platelet activation responsible sepsis-induced coagulopathy severe COVID-19 Shear stress Stress the disease therapeutic option thromboembolic complication Thromboembolic events Thromboembolism thrombosis thrombotic thrombotic event thrombus formation venous while [DOI] 10.1016/j.thromres.2022.02.016 [Article Type] Review article
Pulmonary Embolism (PE) Prevalence in Mexican-Mestizo Patients With Severe SARS-COV-2 (COVID-19) Pneumonia At A Tertiary-Level Hospital: A ReviewReview article Published on 2022-04-012022-10-05 Journal: Current problems in cardiology [Category] 바이오마커, [키워드] addition Analysis Biomarker calculated Cancer Chest Chronic kidney disease Comorbidity COVID-19 criteria Descriptive statistics Diagnosis disease Embolism events groups hypercoagulable Infarction Myocardial obesity Patient patients with SARS performed peripheral arterial thrombosis Pneumonia Prevalence prevalence rate prognostic biomarker pulmonary reported review SARS-CoV2 severe pneumonia student subsegmental systemic arterial hypertension the patient Thromboembolism thrombotic complication treated Type Vascular venous thromboembolic was performed Wilcoxon test Wuhan, China [DOI] 10.1016/j.cpcardiol.2022.101208 [Article Type] Review article
Plasma D-dimer value corrected by inflammatory markers in patients with SARS-CoV-2 infection: Its prognostic value in the diagnosis of venous thromboembolismSARS-CoV-2 감염 환자의 염증 표지자로 교정된 혈장 D-dimer 값: 정맥 혈전색전증 진단에 대한 예후적 가치Article Published on 2022-03-252022-09-11 Journal: Medicina clínica [Category] MERS, SARS, 바이오마커, 치료기술, [키워드] Acute-phase proteins age analyzed benefit best C-reactive protein case-control study Control COVID 19 COVID-19 cut-off cut-off point cutoff point D-dimer D-dimer level D-dimer levels D-dimer value detect determine diagnosed Diagnosis diagnostic diagnostic testing Diagnóstico dimer elevated English ferritin Ferritina FIBRIN fibrin fragment D fibrinogen Fragmento de fibrina D higher risk hospital Inflammatory marker inflammatory markers linear Linear model Linear regression media men Patient patients with SARS-CoV-2 plasma predicted Predictive Probability Prognostic value Proteínas de fase aguda ROC ROC Curve ROC curves screening method sensitivity Sex Spain Spanish specificity Thromboembolism Tromboembolismo venoso Usando Venous Thromboembolism VTE [DOI] 10.1016/j.medcli.2021.03.034 PMC 바로가기 [Article Type] Article
Cardiovascular disturbances in COVID-19: an updated review of the pathophysiology and clinical evidence of cardiovascular damage induced by SARS-CoV-2Review Published on 2022-03-092022-10-27 Journal: BMC Public Health [Category] COVID-19, [키워드] angiotensin-converting enzyme-2 Asymptomatic binding cardiovascular cardiovascular damage cardiovascular disorder Cardiovascular disorders cardiovascular morbidity cardiovascular system cause clinical evidence coronavirus Coronavirus-2 COVID-19 Critical Cytokine storm disease disease manifestation Evolution expresse Follow-up imaging Infection intensive care Mild morbidity and mortality myocarditis outcome pathophysiology patients Perturbation phenotype Phenotypes Positron emission tomography receptor respiratory virus SARS-CoV-2 SARS-COV-2 infection severe disease significantly Symptomatic patients systemic Takotsubo cardiomyopathy the disease Thromboembolism Treatment virus [DOI] 10.1186/s12872-022-02534-8 PMC 바로가기 [Article Type] Review
Cardiovascular disturbances in COVID-19: an updated review of the pathophysiology and clinical evidence of cardiovascular damage induced by SARS-CoV-2Review Published on 2022-03-092022-10-27 Journal: BMC Public Health [Category] Coronavirus, COVID-19, MERS, SARS, [키워드] angiotensin-converting enzyme-2 Asymptomatic binding cardiovascular cardiovascular damage cardiovascular disorder Cardiovascular disorders cardiovascular morbidity cardiovascular system cause clinical evidence coronavirus Coronavirus-2 COVID-19 Critical Cytokine storm disease disease manifestation Evolution expresse Follow-up imaging Infection intensive care Mild morbidity and mortality myocarditis outcome pathophysiology patients Perturbation phenotype Phenotypes Positron emission tomography receptor respiratory virus SARS-CoV-2 SARS-COV-2 infection severe disease significantly Symptomatic patients systemic Takotsubo cardiomyopathy the disease Thromboembolism Treatment virus [DOI] 10.1186/s12872-022-02534-8 PMC 바로가기 [Article Type] Review